Stanislas Pol

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 21

Top Topics

Hepatitis C Virus

Chronic Kidney Disease

Top Venues

Liver international : official journal of the International Association for the Study of the Liver

Alimentary pharmacology & therapeutics

Annals of internal medicine

Hepatology (Baltimore, Md.)

This page only lists publications with an associated author ORCID identifier.

Publications

Stanislas Pol, Alexander J Thompson, Michelle Collins, Elisa Venier, Laurent Cotte, Montserrat Laguno Centeno, Jorge Mera, Thomas Reiberger, Margaret Burroughs, Dimitri G Semizarov, Alexandru M Iacob, Anne Welhaven, Linda M Fredrick, Joseph S Doyle
Effectiveness and safety of glecaprevir/pibrentasvir for 8 weeks in the treatment of patients with acute hepatitis C: A single-arm retrospective study. Hepatology (Baltimore, Md.) (2024)
Thierry Poynard, Olivier Deckmyn, Valentina Peta, Valérie Paradis, Jean-Francois Gautier, Angélique Brzustowski, Pierre Bedossa, Laurent Castera, Stanislas Pol, Dominique Valla, null null
Prospective direct comparison of non-invasive liver tests in outpatients with type 2 diabetes using intention-to-diagnose analysis. Alimentary pharmacology & therapeutics (2023)
Ahmed Arslan Yousuf Awan, Marina C Berenguer, Annette Bruchfeld, Fabrizio Fabrizi, David S Goldberg, Jidong Jia, Nassim Kamar, Rosmawati Mohamed, Mário Guimarães Pessôa, Stanislas Pol, Meghan E Sise, Ethan M Balk, Craig E Gordon, Gaelen P Adam, Michael Cheung, Amy Earley, Paul Martin, Michel Jadoul
Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2022 Clinical Practice Guideline. Annals of internal medicine (2023)
Isabelle Ollivier, Yohann Repesse, Pierre Nahon, Cendrine Chaffaut, Thông Dao, Thi Thu Nga Nguyen, Patrick Marcellin, Dominique Roulot, Victor De Ledinghen, Stanislas Pol, Dominique Guyader, Isabelle Archambeaud, Fabien Zoulim, Frédéric Oberti, Albert Tran, Jean-Pierre Bronowicki, Louis D'Alteroche, Denis Ouzan, Jean-Marie Peron, Jean-Pierre Zarski, Marc Bourliere, Dominique Larrey, Alexandre Louvet, Paul Calès, Armand Abergel, Philippe Mathurin, Ariane Mallat, Jean-Frederic Blanc, Eric Nguyen-Khac, Ghassan Riachi, Laurent Alric, Lawrence Serfaty, Teresa Antonini, Christophe Moreno, Pierre Attali, Dominique Thabut, Christophe Pilette, Jean-Didier Grange, Christine Silvain, Nicolas Carbonell, Brigitte Bernard-Chabert, Odile Goria, Claire Wartelle, Romain Moirand, Christos Christidis, Gabriel Perlemuter, Violaine Ozenne, Jean Henrion, Sophie Hillaire, Vincent Di Martino, Xavier Amiot, Angela Sutton, Nathalie Barget, Sylvie Chevret, Nathalie Ganne-Carrie, null null
ABO blood group does not influence Child-Pugh A cirrhosis outcome: An observational study from CIRRAL and ANRS CO12 CIRVIR cohorts. Liver international : official journal of the International Association for the Study of the Liver 42 (6) (2022)
Stanislas Pol, Clovis Luzivika Nzinga, Hélène Fontaine, Fabrice Carrat, null null
Editorial: similar risk of hepatocellular carcinoma in chronic hepatitis B patients treated with tenofovir or entecavir-new clues from Europe. Authors' reply. Alimentary pharmacology & therapeutics 53 (5) (2021)
Stanislas Pol, Clovis Luzivika Nzinga, Fabrice Carrat
Letter: tenofovir may be superior to entecavir for treatment-naïve chronic hepatitis B patients-authors' reply. Alimentary pharmacology & therapeutics 53 (9) (2021)
Stanislas Pol, null null
Similar 5-year HCC occurrence in Tenofovir- and Entecavir-treated HBV chronic infection in the French AFEF/ANRS CO22 Hepather cohort. Alimentary pharmacology & therapeutics 53 (5) (2021)
Anaïs Vallet-Pichard, Stanislas Pol
Review article: immunisation against hepatitis B virus infection and the prevention of hepatocellular carcinoma. Alimentary pharmacology & therapeutics 53 (11) (2021)
Clémence Hollande, Lucia Parlati, Stanislas Pol
Micro-elimination of hepatitis C virus. Liver international : official journal of the International Association for the Study of the Liver (2021)
Melina Santos, Camelia Protopopescu, Elizabeth Delarocque-Astagneau, Marc Bourlière, Ventzislava Petrov-Sanchez, Vincent Di Beo, Dominique Larrey, Maël Baudoin, Céline Dorival, Morgane Bureau, Hélène Fontaine, Fabrice Carrat, Fabienne Marcellin, Stanislas Pol, Patrizia Maria Carrieri, null null
Late presentation for HCV care: Time to target people with diabetes and/or hazardous alcohol use (ANRS CO22 HEPATHER cohort). Liver international : official journal of the International Association for the Study of the Liver (2021)
Thierry Poynard, Valérie Paradis, Jimmy Mullaert, Olivier Deckmyn, Nathalie Gault, Estelle Marcault, Pauline Manchon, Nassima Si Mohammed, Beatrice Parfait, Mark Ibberson, Jean-Francois Gautier, Christian Boitard, Sébastien Czernichow, Etienne Larger, Fabienne Drane, Jean Marie Castille, Valentina Peta, Angélique Brzustowski, Benoit Terris, Anais Vallet-Pichard, Dominique Roulot, Cédric Laouénan, Pierre Bedossa, Laurent Castera, Stanislas Pol, Dominique Valla, null null
Prospective external validation of a new non-invasive test for the diagnosis of non-alcoholic steatohepatitis in patients with type 2 diabetes. Alimentary pharmacology & therapeutics 54 (7) (2021)
Stanislas Pol, Loriane Lair-Mehiri, Anaïs Vallet-Pichard
Is elimination of HCV realistic by 2030: France. Liver international : official journal of the International Association for the Study of the Liver (2021)
Víctor Sapena, Marco Enea, Ferràn Torres, Ciro Celsa, Jose Ríos, Giacomo Emanuele Maria Rizzo, Pierre Nahon, Zoe Mariño, Ryosuke Tateishi, Tatsuya Minami, Angelo Sangiovanni, Xavier Forns, Hidenori Toyoda, Stefano Brillanti, Fabio Conti, Elisabetta Degasperi, Ming-Lung Yu, Pei-Chien Tsai, Kévin Jean, Mohamed El Kassas, Hend Ibrahim Shousha, Ashraf Omar, Claudio Zavaglia, Hiroko Nagata, Mina Nakagawa, Yasuhiro Asahina, Amit G Singal, Caitlin C Murphy, Mohamed Ahmed Samy Kohla, Chiara Masetti, Jean-François Dufour, Nicolás Merchante, Luisa Cavalletto, Liliana Lc Chemello, Stanislas Pol, Javier Crespo, Jose Luis Calleja, Rosanna Villani, Gaetano Serviddio, Alberto Zanetto, Sarah Shalaby, Francesco Paolo Russo, Rob Bielen, Franco Trevisani, Calogero Cammà, Jordi Bruix, Giuseppe Cabibbo, Maria Reig
Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: an individual patient data meta-analysis. Gut (2021)
Clémence Hollande, Stanislas Pol
Editorial: reciprocal interaction between HCV direct-acting anti-virals (DAA) and hepatocellular carcinoma (HCC)-a negative impact of HCC on sustained virologic response not of DAA on HCC. Alimentary pharmacology & therapeutics 50 (2) (2020)
Stanislas Pol, Anaïs Vallet-Pichard, Hélène Fontaine, Fabrice Carrat
Direct-acting antivirals and the risk of hepatocellular carcinoma: The end of a polemic? Liver international : official journal of the International Association for the Study of the Liver 39 (3) (2020)
Asselah Tarik, Stanislas Pol, Christophe Hezode, Veronique Loustaud-Ratti, Vincent Leroy, Si Nafa Si Ahmed, Violaine Ozenne, Jean-Pierre Bronowicki, Dominique Larrey, Albert Tran, Laurent Alric, Eric Nguyen-Khac, Michael N Robertson, George J Hanna, Deborah Brown, Ernest Asante-Appiah, Feng-Hsiu Su, Peggy Hwang, Jessie Durrand Hall, Amir Guidoum, Karin Hagen, Barbara A Haber, Rohit Talwani, Lawrence Serfaty
Efficacy and safety of elbasvir/grazoprevir for 8 or 12 weeks for hepatitis C virus genotype 4 infection: A randomized study. Liver international : official journal of the International Association for the Study of the Liver 40 (5) (2020)
Stanislas Pol, Lucia Parlati
Treatment of hepatitis C: the use of the new pangenotypic direct-acting antivirals in "special populations". Liver international : official journal of the International Association for the Study of the Liver (2019)
Stanislas Pol, Gonzague Jourdain
Prevention of the mother-to-child transmission of Hepatitis B virus. Liver international : official journal of the International Association for the Study of the Liver 38 (7) (2019)
Lucia Parlati, Anne Laurain, Stanislas Pol
Epidemiology update for HCV and HBV in ESRD in France: Still a lot to do. Liver international : official journal of the International Association for the Study of the Liver 37 (6) (2018)
K Rajender Reddy, Stanislas Pol, Paul J Thuluvath, Hiromitsu Kumada, Joji Toyota, Kazuaki Chayama, James Levin, Eric J Lawitz, Adrian Gadano, Wayne Ghesquiere, Guido Gerken, Maurizia R Brunetto, Cheng-Yuan Peng, Marcelo Silva, Simone I Strasser, Jeong Heo, Fiona McPhee, Zhaohui Liu, Rong Yang, Misti Linaberry, Stephanie Noviello
Long-term follow-up of clinical trial patients treated for chronic HCV infection with daclatasvir-based regimens. Liver international : official journal of the International Association for the Study of the Liver 38 (5) (2017)
Luca Arcaini, Caroline Besson, Marco Frigeni, Hélène Fontaine, Maria Goldaniga, Milvia Casato, Marcella Visentini, Harrys A Torres, Veronique Loustaud-Ratti, Jan Peveling-Oberhag, Paolo Fabris, Roberto Rossotti, Francesco Zaja, Luigi Rigacci, Sara Rattotti, Raffaele Bruno, Michele Merli, Céline Dorival, Laurent Alric, Arnaud Jaccard, Stanislas Pol, Fabrice Carrat, Virginia Valeria Ferretti, Chiara Rusconi, Olivier Hermine
Interferon-free antiviral treatment in B-cell lymphoproliferative disorders associated with hepatitis C virus infection. Blood 128 (21) (2016)